Case Report: Iliopsoas Hematoma during the Clinical Course of Severe COVID-19 in Two Male Patients.
Am J Trop Med Hyg
; 104(3): 1018-1021, 2021 Jan 13.
Article
in English
| MEDLINE | ID: covidwho-1175680
ABSTRACT
Anticoagulation plays a major role in reducing the risk of systematic thrombosis in patients with severe COVID-19. Serious hemorrhagic complications, such as intracranial hemorrhage, have also been recognized. However, intra-abdominal hemorrhage is under-recognized because of its rare occurrence, despite high mortality. Here, we discuss two cases of spontaneous iliopsoas hematoma (IPH) likely caused by anticoagulants during the clinical course of COVID-19. We also explored published case reports to identify clinical characteristics of IPH in COVID-19 patients. The use of anticoagulants may increase the risk of lethal IPH among COVID-19 patients becsuse of scarce data on optimal dosage and adequate monitoring of anticoagulant effects. Rapid diagnosis and timely intervention are crucial to ensure good patient outcomes.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Muscle, Skeletal
/
Abscess
/
COVID-19
/
Hematoma
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
/
Systematic review/Meta Analysis
Topics:
Long Covid
Limits:
Aged
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Am J Trop Med Hyg
Year:
2021
Document Type:
Article
Affiliation country:
Ajtmh.20-1507
Similar
MEDLINE
...
LILACS
LIS